- Category: Business
Business
Updated reciprocal tariffs to take effect this week
With new rates hitting Aug. 7, take a look at how the optical industry will be impacted as top trade partners face an increase on U.S. imports.
Business
Alcon to acquire STAAR Surgical
The $1.5 billion deal includes STAAR’s FDA-approved implantable collamer lenses; expected to close within 6 to 12 months.
Business
Topcon acquires Intelligent Retinal Imaging Systems
As part of the
Business
Leadership watch: PolyActiva, B+L, and Wills Eye make strategic changes
Check out the latest leadership news from the eyecare space, including two new execs at PolyActiva and a retinal disorder treatment specialist taking the helm at Wills Eye.
Business
Topcon invests in OKKO Health's home vision monitoring platform
The OKKO Health app is available on patients’ digital devices to enable ongoing self-monitoring of macular degeneration.
Business
Clearside exploring options to advance suprachoroidal delivery platform
Company pauses all other research programs, transitions employees to consulting roles, and shares phase 3 plans for wet AMD candidate while focusing on the SCS Microinjector.
Business
Harrow purchases US commercialization rights to Samsung Bioepis' biosimilar portfolio
Acquisition includes two major anti-VEGF therapies for retinal diseases: OPUVIZ and BYOOVIZ, generic equivalents to EYLEA and Lucentis, respectively.
Business
Meta reportedly buys minority stake in EssilorLuxottica
The estimated $3.51 billion investment follows companies’ recent plans to launch AI-powered smart glasses for the Oakley sports performance frames this summer.
Business
Leadership watch: ViaLase, J&J, Alcon, and myze make executive additions
Check out the latest leadership news from the eyecare space, including a new CEO at ViaLase and a leading optometrist joining myze.
Business
4DMT cuts 25% of workforce and fast-tracks wet AMD gene therapy program
Company reports streamlined planning to advance phase 3 clinical trials of 4D-150, under evaluation to deliver a single, low-dose, and sustained multi-year intravitreal injection.
Business
Alcon to purchase LumiThera
Targeting a Q3 sale, acquisition includes Valeda Light Delivery System, the first and only PBM treatment for early-to-intermediate dry AMD.
Business
Eyenovia rebrands as Hyperion DeFi, Inc with new focus
Name change aligns with company's pivot toward decentralized finance and focus on a cryptocurrency treasury reserve strategy; plans remain to commercialize Optejet.
Business
AOA inducts new leadership during 2025 Optometry's Meeting
Vowing pushback against vision plan abuses, Jacquie M. Bowen, OD, is named president as the 2025-2026 AOA Board of Trustees are inducted.
Business
ForSight Robotics raises $125M to advance robotic ophthalmic surgical platform
Financing to support expansion of ORYOM, the world’s first hybrid intraocular ophthalmic platform designed to deliver advanced capabilities beyond standard cataract surgery.
Business
Amaros secures Series A financing for AI ophthalmic evidence platform
Financing will support adoption and commercialization of the EvidenceEngine to accelerate clinical trial enrollment and generate real-world evidence on retinal disease.
Business
1-800 Contacts launches digital eyewear retail store
Online contact lens retailer debuts new frame and lens e-commerce shop with prescription integration, virtual and in-home try-ons, and cost-effective options.
Business
Pangaea Data's AI platform receives Topcon investment
Collaboration involves the PALLUX, which will analyze patient records against clinical guidelines and identify untreated and undiagnosed patients with ocular and systemic diseases.
Business
Therini Bio raises nearly $40M to study DME and Alzheimer's immunotherapeutics
Funding to support two trials on fibrin-targeting immunotherapies targeting vascular dysfunction-induced neuroinflammation in severe retinal and neurological diseases.
Business
Topcon invests in MedTech startup’s microdosing drug delivery system
Collaboration involves MistGo Digital, under clinical development as a drug delivery system combined with a digital adherence monitoring platform.
Business